Other
N/A - No intervention
N/A - No intervention is an intervention with 5 clinical trials. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(20%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Enrolling by invitation1
Terminated1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
66.7%
Trials by Status
enrolling_by_invitation120%
completed240%
terminated120%
not_yet_recruiting120%
Recent Activity
0 active trials
Showing 5 of 5
enrolling_by_invitation
Ascertaining Longterm Outcomes of Fibroid Treatments
NCT06430320
completed
The Identification of Phenotypes in Patients With Severe Chronic Obstructive Pulmonary Disease (Groningen Severe COPD Cohort)
NCT04023409
not_yet_recruiting
Genomic Profiling of Pancreatic Cystic Tumors
NCT06195904
completed
Understanding COVID-19
NCT04329546
terminated
Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial
NCT02308735
Clinical Trials (5)
Showing 5 of 5 trials
NCT06430320
Ascertaining Longterm Outcomes of Fibroid Treatments
NCT04023409
The Identification of Phenotypes in Patients With Severe Chronic Obstructive Pulmonary Disease (Groningen Severe COPD Cohort)
NCT06195904
Genomic Profiling of Pancreatic Cystic Tumors
NCT04329546
Understanding COVID-19
NCT02308735
Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5